Item 2.02. Results of Operations and Financial Condition.
On August 5, 2021, Provention Bio, Inc. (the "Company") issued a press release
regarding financial results for the fiscal quarter ended June 30, 2021 and
discussing its business outlook. A copy of the press release is attached as
Exhibit 99.1 to this Current Report on Form 8-K and is incorporated herein by
reference.
The information in this Current Report on Form 8-K under this Item 2.02,
including the information contained in Exhibit 99.1, is being furnished to the
Securities and Exchange Commission, and shall not be deemed to be "filed" for
purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the
"Exchange Act") or otherwise subject to the liabilities of that section, and
shall not be deemed to be incorporated by reference into any filing under the
Securities Act of 1933, as amended, or the Exchange Act, except as shall be
expressly set forth by a specific reference in such filing.
Item 9.01 Financial Statements and Exhibits.
(d) The following exhibit is furnished with this report:
Exhibit No. Description
99.1 Press Release issued by Provention Bio, Inc. on August 5, 2021
104 Cover Page Interactive Data File (formatted as Inline XBRL)
© Edgar Online, source Glimpses